Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 225,250 | 119,497 | 324,505 | 144,207 | 188,411 |
| Cost of Goods | 4,164 | 2,151 | 3,062 | 2,191 | 2,537 |
| Gross Profit | 221,086 | 117,346 | 321,443 | 142,016 | 185,874 |
| Operating Expenses | 287,341 | 267,010 | 327,627 | 285,472 | 276,606 |
| Operating Income | -66,091 | -149,513 | -6,122 | -143,265 | -90,195 |
| Interest Expense | 22,786 | 22,110 | 22,406 | 21,982 | 19,946 |
| Other Income | 22,676 | 28,895 | 25,762 | 24,439 | 32,693 |
| Pre-tax Income | -66,201 | -142,728 | -2,766 | -140,808 | -77,448 |
| Income Tax | 64 | 75 | 6,497 | 6,602 | 7,842 |
| Net Income Continuous | -66,265 | -142,803 | -9,263 | -147,410 | -85,290 |
| Net Income | $-66,265 | $-142,803 | $-9,263 | $-147,410 | $-85,290 |
| EPS Basic Total Ops | -0.45 | -0.98 | -0.06 | -1.03 | -0.60 |
| EPS Basic Continuous Ops | -0.45 | -0.98 | -0.06 | -1.03 | -0.60 |
| EPS Diluted Total Ops | -0.45 | -0.98 | -0.06 | -1.03 | -0.60 |
| EPS Diluted Continuous Ops | -0.45 | -0.98 | -0.06 | -1.03 | -0.60 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.98 | -0.06 | N/A | N/A |
| EBITDA(a) | $-68,727 | $-151,452 | $-7,335 | $-143,889 | $-90,465 |